Search research articles
Contact Us
Filters
Showing results (1-10 of 28) with videos related to
Page
of 3
Sort By:
Diabetes
|
October 27, 2004
Fas deficiency prevents type 1 diabetes by inducing hyporesponsiveness in islet beta-cell-reactive T-cells
Luis Vence, Christophe Benoist, Diane Mathis
Expert Review of Vaccines
|
June 4, 2010
Development and application of 'phosphoflow' as a tool for immunomonitoring
Sheng Wu, Lei Jin, Luis Vence, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
December 2, 2009
MART-1-specific melanoma tumor-infiltrating lymphocytes maintaining CD28 expression have improved survival and expansion capability following antigenic restimulation in vitro
Yufeng Li, Shujuan Liu, Jessica Hernandez, et al.
Cancer Immunology, Immunotherapy : CII
|
October 8, 2021
Effects of combination treatment with durvalumab plus tremelimumab on the tumor microenvironment in non-small-cell lung carcinoma
Li Cheng, Todd Creasy, Fernanda Pilataxi, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
December 21, 2007
Circulating tumor antigen-specific regulatory T cells in patients with metastatic melanoma
Luis Vence, A Karolina Palucka, Joseph W Fay, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
June 5, 2019
Anti-CTLA-4 Immunotherapy Does Not Deplete FOXP3<sup>+</sup> Regulatory T Cells (Tregs) in Human Cancers-Response
Anu Sharma, Sumit K Subudhi, Jorge Blando, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
July 29, 2018
Anti-CTLA-4 Immunotherapy Does Not Deplete FOXP3<sup>+</sup> Regulatory T Cells (Tregs) in Human Cancers
Anu Sharma, Sumit K Subudhi, Jorge Blando, et al.
International Journal of Oncology
|
January 1, 2010
Cytotoxic effects of ultra-diluted remedies on breast cancer cells
Moshe Frenkel, Bal Mukund Mishra, Subrata Sen, et al.
Cancer Immunology Research
|
July 11, 2019
Immunologic Correlates of Pathologic Complete Response to Preoperative Immunotherapy in Hepatocellular Carcinoma
Ahmed Omar Kaseb, Luis Vence, Jorge Blando, et al.
Journal of Hematology & Oncology
|
September 7, 2016
Selective inhibition of autoimmune exacerbation while preserving the anti-tumor clinical benefit using IL-6 blockade in a patient with advanced melanoma and Crohn's disease: a case report
Marc Uemura, Van A Trinh, Cara Haymaker, et al.
Page
of 3
Search research articles
Search
Showing results (1-10 of 28) with videos related to
Sort By:
Page
of 3
Diabetes
|
October 27, 2004
Fas deficiency prevents type 1 diabetes by inducing hyporesponsiveness in islet beta-cell-reactive T-cells
Luis Vence, Christophe Benoist, Diane Mathis
Expert Review of Vaccines
|
June 4, 2010
Development and application of 'phosphoflow' as a tool for immunomonitoring
Sheng Wu, Lei Jin, Luis Vence, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
December 2, 2009
MART-1-specific melanoma tumor-infiltrating lymphocytes maintaining CD28 expression have improved survival and expansion capability following antigenic restimulation in vitro
Yufeng Li, Shujuan Liu, Jessica Hernandez, et al.
Cancer Immunology, Immunotherapy : CII
|
October 8, 2021
Effects of combination treatment with durvalumab plus tremelimumab on the tumor microenvironment in non-small-cell lung carcinoma
Li Cheng, Todd Creasy, Fernanda Pilataxi, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
December 21, 2007
Circulating tumor antigen-specific regulatory T cells in patients with metastatic melanoma
Luis Vence, A Karolina Palucka, Joseph W Fay, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
June 5, 2019
Anti-CTLA-4 Immunotherapy Does Not Deplete FOXP3<sup>+</sup> Regulatory T Cells (Tregs) in Human Cancers-Response
Anu Sharma, Sumit K Subudhi, Jorge Blando, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
July 29, 2018
Anti-CTLA-4 Immunotherapy Does Not Deplete FOXP3<sup>+</sup> Regulatory T Cells (Tregs) in Human Cancers
Anu Sharma, Sumit K Subudhi, Jorge Blando, et al.
International Journal of Oncology
|
January 1, 2010
Cytotoxic effects of ultra-diluted remedies on breast cancer cells
Moshe Frenkel, Bal Mukund Mishra, Subrata Sen, et al.
Cancer Immunology Research
|
July 11, 2019
Immunologic Correlates of Pathologic Complete Response to Preoperative Immunotherapy in Hepatocellular Carcinoma
Ahmed Omar Kaseb, Luis Vence, Jorge Blando, et al.
Journal of Hematology & Oncology
|
September 7, 2016
Selective inhibition of autoimmune exacerbation while preserving the anti-tumor clinical benefit using IL-6 blockade in a patient with advanced melanoma and Crohn's disease: a case report
Marc Uemura, Van A Trinh, Cara Haymaker, et al.
Page
of 3